In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

announced the expansion of its industry-leading formulary of more than a dozen medications to include compounded oral semaglutide dissolving tablets. This needle-free option requires no ...

Besides diabetes, obesity is a major risk factor for hypertension and heart disease, creating what can only be described as a ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

Denmark’s Novo Nordisk saw its shares rise as much as 13% to 659.20 kroner this morning, after it announced top-line results ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

"With this first-of-its-kind gummy, we've removed barriers like needles and discomfort ... easier option than oral semaglutide droppers. In addition to the innovative format, Eden connects ...

Semaglutide is the cornerstone of GetSimpli ... This method eliminates the need for needles and syringes, making it a more comfortable option for those who may have anxiety about injections ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.